Factors affecting the persistence of drug-induced reprogramming of the cancer methylome

Aberrant DNA methylation is a critical feature of cancer. Epigenetic therapy seeks to reverse these changes to restore normal gene expression. DNA demethylating agents, including 5-aza-2′-deoxycytidine (DAC), are currently used to treat certain leukemias, and can sensitize solid tumors to chemothera...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Epigenetics
Egile Nagusiak: Bell, Joshua S. K., Kagey, Jacob D., Barwick, Benjamin G., Dwivedi, Bhakti, McCabe, Michael T., Kowalski, Jeanne, Vertino, Paula M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889262/
https://ncbi.nlm.nih.gov/pubmed/27082926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2016.1158364
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak